Power Analysis Example


Good example to use for evaluating the power analysis

View/Edit Study Name Start Date Study Types  Experimental Models Model Types Disease(s) Data Points Data Points (omic) Images Videos Plate Maps Plate Reader Files Supporting Data Files Description Reproducibility Status Center Data Entry Review Sign Off Date Data Provider ID
View/Edit UPLiver_Tier2c_3D 2018-08-31 TOX SQL-SAL 1.5 Fluidic-3D -No Diseases- 2,150 0 54 0 0 0 2 This tier of testing was part of the 3D “Toxicity” study to measure the effects of drugs on cells seeded in SQL-SAL tissue chips. In this study, 27 chips (Nortis, Inc.) were seeded with iPSC-derived hepatocytes from CDI, as well as supporting cells (LX-2, EA.Hy926, and THP-1) in a layered collagen matrix. Cultures were treated with either a vehicle (0.1% DMSO, n=3), caffeine (600uM, n=3), trovafloxacin (150uM, n=3), troglitazone (28uM, n=3), tolcapone (88uM, n=3), rosiglitazone (0.8uM, n=3), pioglitazone (3uM, n=3), trovaflocacin + LPS (150uM + 1ug/mL, n=3), or LPS (1ug/mL, n=3). Cells were cultured over 10 days with daily media sampling. Media was tested for flow rate, Albumin, Urea-Nitrogen, LDH, and TNF-a, as well as the presence of the parent drug compounds. Additionally, viability testing was carried out at endpoint. TEX-VAL Michael Castiglione 4 2019-07-11 Rusyn_TAMU 225
Show/Hide Plots
With the current selections, there are points with caution flags and excluded points.
No charts to display
Custom Groups